Drugs and Devices

New safety information for Invirase

The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir). The warning describes potentially life-threatening cardiovascular side effects the drug is used with Norvir (ritonavir). Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230442.htm.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares